• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Sarepta Therapeutics, Inc. (SRPT)

    -NasdaqGS
    30.14 Up 0.39(1.31%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:29.75
    Open:29.69
    Bid:29.50 x 200
    Ask:32.50 x 100
    1y Target Est:30.36
    Beta:0.3
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:29.38 - 30.43
    52wk Range:11.33 - 33.16
    Volume:663,607
    Avg Vol (3m):1,600,110
    Market Cap:1.25B
    P/E (ttm):N/A
    EPS (ttm):-4.13
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SRPT

    Comparison

    Symbol% ChgMkt Cap
    SRPTUp 1.31%1.25B
    ALNYUp 0.23%9.93B
    GSKUp 0.28%102.06B
    ISISDown 1.80%6.72B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):336.23
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-4.83
    Quarterly EPS Est (Jun-15) :-1.19
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):31.50

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback